Crinetics Pharmaceuticals CRNX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$496.39M-51.2% | -$465.32M-55.9% | -$423.1M-52.2% | -$369.83M-43.0% | -$328.25M-39.4% | ||
| $4.13M+27.5% | $3.89M+39.7% | $3.68M+63.1% | $3.44M+95.3% | $3.24M+151% | ||
| $100.23M+31.2% | $91.02M+31.2% | $88.15M+41.8% | $83.59M+51.8% | $76.41M+65.1% | ||
| -$414.17M-55.8% | -$377.92M-64.2% | -$351.89M-72.4% | -$304M-66.4% | -$265.79M-47.1% | ||
| $5.34M+42.4% | $5.76M+49.9% | $6.33M+68.9% | $6M-10.8% | $3.75M-37.5% | ||
| $7.51M+101% | $173.91M+129% | -$425.29M-202% | -$590.1M-76.7% | -$681.69M-174% | ||
| $426.05M-31.9% | $40.61M-96.0% | $570.81M+14.5% | $625.05M-19.8% | $625.52M-20.2% | ||
| —— | —— | —— | —— | —— | ||
| -$419.52M-55.6% | -$383.68M-63.9% | -$358.23M-72.3% | -$310M-63.7% | -$269.54M-44.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Crinetics Pharmaceuticals's cash flow data come from?
- Every line is extracted from Crinetics Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.